The Federation of State Medical Boards (FSMB) and NBME, co-patrons of the United States Medical Licensing Examination® (USMLE®), are today declaring the suspension of work to relaunch an altered Step 2 Clinical Skills assessment (Step 2 CS).
Following the May 2020 suspension of Step 2 CS because of the COVID-19 pandemic, we declared our aim to require 12-year and a half to bring back a changed Step 2 CS test that was considerably in a way that is better than the earlier evaluation. In the wake of looking into current and foreseen progress with the test and regarding the quickly developing clinical schooling, practice and innovation scenes, we have chosen to stop Step 2 CS. We have no designs to bring back Step 2 CS, however we plan to accept this open door to zero in on working with our partners in clinical schooling and at the state clinical sheets to decide imaginative approaches to survey clinical abilities.
Autonomous normalized appraisals of clinical information and clinical abilities are significant contributions for state clinical licensure choices. Without Step 2 CS, components of clinical thinking and correspondence will keep on being surveyed on different tests (Steps) in the USMLE grouping. PC based case recreations in Step 3 and correspondence content as of late reinforced in Step 1 are instances of these endeavors that will proceed. While not a swap for Step 2 CS, these configurations keep on contributing emphatically, e.g., estimating basic information on clinical correspondence.
Our adjustment in course will permit us to set aside extra effort to collaborate with the clinical instruction and clinical board local area to more readily create inventive approaches to survey the expansiveness of clinical abilities in medication.
For inquiries concerning the Step 2 CS cessation and some other USMLE-related requests please contact the USMLE uphold group: https://www.usmle.org/contact/
“The FSMB is focused on supporting state clinical sheets in their chief mission to ensure people in general,” said Humayun J. Chaudhry, DO, MACP, President and CEO of the FSMB. “As co-patrons of the USMLE program, we will keep on looking for imaginative and reasonable approaches to survey clinical authorizing qualification.”
“NBME’s obligation to execution based appraisal and clinical abilities has quickened. Our freshest region of center around competency – based evaluation, and our investigation of novel appraisals, will permit us to work with the clinical instruction and administrative networks to create appraisals of these fundamental abilities and the ideal method to incorporate these appraisals into the training and licensure space,” said Peter J. Katsufrakis, MD, MBA, President and CEO, NBME.
ECFMG will keep on administering prerequisites for its confirmation of International Medical Graduates (IMGs) and has reported an extension of its pathways that will permit qualified IMGs to meet the necessities for ECFMG Certification and to keep on pursuing U.S. graduate clinical instruction.